Internal Medicine

Prof. Dr. Yücel Arman

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
Insulin ResistanceHeart FailureDiabetes Mellitus, Type 2Coronary Artery DiseaseHypertension
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Insulin Resistance 6 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Heart Failure 3 publications
  • Diabetes Mellitus, Type 2 3 publications
  • Coronary Artery Disease 2 publications
  • Hypertension 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workInsulin ResistanceExtracted from 6 publications · Model version —From source
  • Publications51 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0002-9584-6644ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563381/doktorlarimiz.html#yucel-armansaglik.gov.tr

Scientific work

Publications on Insulin Resistance

51 publications

  1. The Relationship Between Serum Endocan Levels and Macrophage Activation Syndrome in COVID-19 Patients

    Archives of Current Medical Research, 2026

    DOI 10.47482/acmr.1727140 Open-access full textSource: ORCID

  2. Lower Serum Kindlin-2 Levels Are Associated with Liver Cirrhosis: A Preliminary Study

    Hepatitis Monthly, 2026

    DOI 10.5812/hepatmon-173193 Open-access full textSource: OpenAlex

  3. The Association Between Depression and Antidiabetic Treatments in Type 2 Diabetes Patients with Both Good and Poor Glycemic Control

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14103460 PMID 40429455 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. THE RELATION OF SERUM NESFATIN-1 LEVELS WITH DISEASE SEVERITY AND COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS

    Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2024

    DOI 10.26650/iuitfd.1365883 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  5. Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction.

    PubMed Central, 2024

    DOI 10.6515/acs.202405_40(3).20240128a PMID 38779167 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. The relation of serum nesfatin-1 levels with disease severity and complications in patients with liver cirrhosis

    Journal of Hepatology, 2023

    DOI 10.1016/s0168-8278(23)00861-9 Source: OpenAlex

  7. Diagnostic and prognostic value of Nesfatin-1 in sepsis and septic shock

    Journal of Experimental and Clinical Medicine, 2022

    DOI 10.52142/omujecm.39.1.1 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. Granulomatous Inflammation in a Patient with ALK-Negative Anaplastic Large Cell Lymphoma

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022

    DOI 10.4274/tjh.galenos.2021.2021.0367 PMID 34753277 Open-access full textSource: Europe PMC

  9. Can the Serum Endocan Level Be Used as a Biomarker to Predict Subclinical Atherosclerosis in Patients with Prediabetes?

    Arquivos brasileiros de cardiologia, 2022

    DOI 10.36660/abc.20210797 PMID 35946756 7 citations (Europe PMC) Open-access full textSource: Europe PMC

  10. THE RELATIONSHIP BETWEEN sTREM-1 AND ACTIVATION OF INFLAMMATORY BOWEL DISEASES

    Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2021

    DOI 10.26650/iuitfd.2020.0090 2 citations (OpenAlex) Open-access full textSource: OpenAlex

View all 51 publications